Strs Ohio Purchases Shares of 18,817 Solventum Corporation $SOLV

Key Points

• Strs Ohio has purchased 18,817 shares of Solventum Corporation for approximately $1.43 million, according to its recent SEC filing.
• Shares of Solventum traded up 0.5% to $74.42, with a market capitalization of $12.90 billion and a P/E ratio of 13.25.
• Analyst ratings for Solventum show a mix of opinions, with one strong buy, several buy ratings, and a consensus average price target of $85.44.

Strs Ohio acquired a new position in Solventum Corporation (NYSE:SOLV - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 18,817 shares of the company's stock, valued at approximately $1,431,000.

Other large investors have also recently made changes to their positions in the company. Banque Transatlantique SA grew its position in shares of Solventum by 9,219.8% in the 1st quarter. Banque Transatlantique SA now owns 59,274 shares of the company's stock worth $4,165,000 after buying an additional 58,638 shares during the last quarter. Concurrent Investment Advisors LLC bought a new stake in shares of Solventum during the first quarter valued at approximately $216,000. Jones Financial Companies Lllp boosted its position in shares of Solventum by 3,484.6% during the first quarter. Jones Financial Companies Lllp now owns 120,656 shares of the company's stock valued at $9,175,000 after purchasing an additional 117,290 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of Solventum by 17.1% during the first quarter. Bessemer Group Inc. now owns 1,963 shares of the company's stock valued at $150,000 after purchasing an additional 287 shares in the last quarter. Finally, Comerica Bank boosted its position in shares of Solventum by 39.7% during the first quarter. Comerica Bank now owns 77,725 shares of the company's stock valued at $5,910,000 after purchasing an additional 22,079 shares in the last quarter.

Solventum Stock Performance

Solventum stock traded down $0.60 during mid-day trading on Friday, reaching $73.77. 1,491,907 shares of the stock traded hands, compared to its average volume of 1,045,100. The stock has a market capitalization of $12.79 billion, a PE ratio of 34.15, a price-to-earnings-growth ratio of 3.00 and a beta of 0.53. The company has a debt-to-equity ratio of 2.14, a current ratio of 1.22 and a quick ratio of 0.86. Solventum Corporation has a 12-month low of $60.70 and a 12-month high of $85.92. The business's 50-day moving average is $72.98 and its 200-day moving average is $72.35.

Solventum (NYSE:SOLV - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $1.69 EPS for the quarter, beating analysts' consensus estimates of $1.45 by $0.24. The company had revenue of $2.16 billion during the quarter, compared to analysts' expectations of $2.12 billion. Solventum had a return on equity of 29.93% and a net margin of 4.52%.Solventum's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.56 earnings per share. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, sell-side analysts predict that Solventum Corporation will post 6.58 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on SOLV shares. Argus upgraded Solventum from a "hold" rating to a "buy" rating and set a $90.00 price target on the stock in a research report on Tuesday, July 1st. Wall Street Zen downgraded Solventum from a "strong-buy" rating to a "buy" rating in a report on Tuesday, September 9th. Jefferies Financial Group started coverage on Solventum in a report on Thursday, September 11th. They issued a "hold" rating and a $80.00 target price on the stock. Wells Fargo & Company boosted their target price on Solventum from $79.00 to $82.00 and gave the stock an "equal weight" rating in a report on Monday, September 15th. Finally, KeyCorp started coverage on Solventum in a report on Friday, June 6th. They issued a "sector weight" rating on the stock. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Solventum has an average rating of "Hold" and an average target price of $85.44.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.